Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.

Jordan CJ, Harvey RC, Baskin BB, Dwoskin LP, Kantak KM.

Drug Alcohol Depend. 2014 Jul 1;140:25-32. doi: 10.1016/j.drugalcdep.2014.04.020. Epub 2014 Apr 28.

PMID:
24811203
[PubMed - indexed for MEDLINE]
2.

Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.

Somkuwar SS, Jordan CJ, Kantak KM, Dwoskin LP.

Neuropsychopharmacology. 2013 Dec;38(13):2588-97. doi: 10.1038/npp.2013.163. Epub 2013 Jul 3.

PMID:
23822950
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.

Harvey RC, Jordan CJ, Tassin DH, Moody KR, Dwoskin LP, Kantak KM.

Behav Brain Res. 2013 May 1;244:38-47. doi: 10.1016/j.bbr.2013.01.027. Epub 2013 Jan 31.

PMID:
23376704
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.

Harvey RC, Sen S, Deaciuc A, Dwoskin LP, Kantak KM.

Neuropsychopharmacology. 2011 Mar;36(4):837-47. doi: 10.1038/npp.2010.223. Epub 2010 Dec 8.

PMID:
21150910
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.

Somkuwar SS, Darna M, Kantak KM, Dwoskin LP.

Biochem Pharmacol. 2013 Jul 15;86(2):309-16. doi: 10.1016/j.bcp.2013.04.013. Epub 2013 Apr 23.

PMID:
23623751
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Methylphenidate treatment in the spontaneously hypertensive rat: influence on methylphenidate self-administration and reinstatement in comparison with Wistar rats.

dela Peña I, Yoon SY, Lee JC, dela Peña JB, Sohn AR, Ryu JH, Shin CY, Cheong JH.

Psychopharmacology (Berl). 2012 May;221(2):217-26. doi: 10.1007/s00213-011-2564-1. Epub 2011 Nov 17.

PMID:
22086360
[PubMed - indexed for MEDLINE]
7.

Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.

Soeters HS, Howells FM, Russell VA.

Metab Brain Dis. 2008 Sep;23(3):303-14. doi: 10.1007/s11011-008-9098-1. Epub 2008 Jul 30.

PMID:
18665438
[PubMed - indexed for MEDLINE]
8.

Drug reinforcement in a rat model of attention deficit/hyperactivity disorder--the Spontaneously Hypertensive Rat (SHR).

Vendruscolo LF, Izídio GS, Takahashi RN.

Curr Drug Abuse Rev. 2009 May;2(2):177-83. Review.

PMID:
19630747
[PubMed - indexed for MEDLINE]
9.

Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.

dela Peńa IC, Ahn HS, Choi JY, Shin CY, Ryu JH, Cheong JH.

Behav Pharmacol. 2011 Feb;22(1):31-9. doi: 10.1097/FBP.0b013e328342503a.

PMID:
21160423
[PubMed - indexed for MEDLINE]
10.

Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.

Cao AH, Yu L, Wang YW, Wang JM, Yang LJ, Lei GF.

Behav Brain Funct. 2012 Feb 28;8(1):10. doi: 10.1186/1744-9081-8-10.

PMID:
22369105
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.

Bizot JC, Chenault N, Houzé B, Herpin A, David S, Pothion S, Trovero F.

Psychopharmacology (Berl). 2007 Aug;193(2):215-23. Epub 2007 Apr 4.

PMID:
17406857
[PubMed - indexed for MEDLINE]
12.

Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD).

dela Peña I, Kim HJ, Sohn A, Kim BN, Han DH, Ryu JH, Shin CY, Noh M, Cheong JH.

Behav Brain Funct. 2014 May 6;10:17. doi: 10.1186/1744-9081-10-17.

PMID:
24884696
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder.

Marusich JA, McCuddy WT, Beckmann JS, Gipson CD, Bardo MT.

Behav Pharmacol. 2011 Dec;22(8):794-804. doi: 10.1097/FBP.0b013e32834d623e.

PMID:
22015805
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
[PubMed - indexed for MEDLINE]
15.

Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.

van den Bergh FS, Bloemarts E, Chan JS, Groenink L, Olivier B, Oosting RS.

Pharmacol Biochem Behav. 2006 Mar;83(3):380-90. Epub 2006 Mar 6.

PMID:
16580713
[PubMed - indexed for MEDLINE]
16.

Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.

Baskin BM, Dwoskin LP, Kantak KM.

Pharmacol Biochem Behav. 2015 Jan 31;131C:51-56. doi: 10.1016/j.pbb.2015.01.019. [Epub ahead of print]

PMID:
25643872
[PubMed - as supplied by publisher]
17.

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.

PMID:
17874862
[PubMed - indexed for MEDLINE]
Free Article
18.

Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?

Dela Peña I, Kim BN, Han DH, Kim Y, Cheong JH.

Arch Pharm Res. 2013 Apr;36(4):400-10. doi: 10.1007/s12272-013-0037-2. Epub 2013 Mar 8. Review. Erratum in: Arch Pharm Res. 2013 May;36(5):650. Kim, Bung-Nyun [added]; Han, Doug Hyun [added]; Kim, Yeni [added].

PMID:
23471559
[PubMed - indexed for MEDLINE]
19.

Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment.

dela Peña I, Lee JC, Lee HL, Woo TS, Lee HC, Sohn AR, Cheong JH.

Neurosci Lett. 2012 Apr 18;514(2):189-93. doi: 10.1016/j.neulet.2012.02.090. Epub 2012 Mar 5.

PMID:
22414863
[PubMed - indexed for MEDLINE]
20.

Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.

Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.

Neuroscience. 2010 Jun 2;167(4):1183-91. doi: 10.1016/j.neuroscience.2010.02.073. Epub 2010 Mar 6.

PMID:
20211696
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk